179 related articles for article (PubMed ID: 9210684)
1. Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis.
Lutz JE; Clemons KV; Aristizabal BH; Stevens DA
Antimicrob Agents Chemother; 1997 Jul; 41(7):1558-61. PubMed ID: 9210684
[TBL] [Abstract][Full Text] [Related]
2. Activities of the triazole SCH 51048 against Coccidioides immitis in vitro and in vivo.
Clemons KV; Homola ME; Stevens DA
Antimicrob Agents Chemother; 1995 May; 39(5):1169-72. PubMed ID: 7625808
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of SCH39304 and fluconazole in a murine model of disseminated coccidioidomycosis.
Clemons KV; Hanson LH; Perlman AM; Stevens DA
Antimicrob Agents Chemother; 1990 May; 34(5):928-30. PubMed ID: 2360832
[TBL] [Abstract][Full Text] [Related]
4. Large-Scale Evaluation of
Thompson GR; Barker BM; Wiederhold NP
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096163
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of the triazole Bay R 3783 in mouse models of coccidioidomycosis, blastomycosis, and histoplasmosis.
Pappagianis D; Zimmer BL; Theodoropoulos G; Plempel M; Hector RF
Antimicrob Agents Chemother; 1990 Jun; 34(6):1132-8. PubMed ID: 2393272
[TBL] [Abstract][Full Text] [Related]
6. Efficacies of amphotericin B lipid complex (ABLC) and conventional amphotericin B against murine coccidioidomycosis.
Clemons KV; Stevens DA
J Antimicrob Chemother; 1992 Sep; 30(3):353-63. PubMed ID: 1452501
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis.
Sugar AM; Liu XP
Antimicrob Agents Chemother; 1996 May; 40(5):1314-6. PubMed ID: 8723494
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo activities of posaconazole against Coccidioides immitis.
González GM; Tijerina R; Najvar LK; Bocanegra R; Rinaldi M; Loebenberg D; Graybill JR
Antimicrob Agents Chemother; 2002 May; 46(5):1352-6. PubMed ID: 11959568
[TBL] [Abstract][Full Text] [Related]
9. Efficacies of two novel azole derivatives each containing a morpholine ring, UR-9746 and UR-9751, against systemic murine coccidioidomycosis.
Clemons KV; Stevens DA
Antimicrob Agents Chemother; 1997 Jan; 41(1):200-3. PubMed ID: 8980782
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus.
Oakley KL; Morrissey G; Denning DW
Antimicrob Agents Chemother; 1997 Jul; 41(7):1504-7. PubMed ID: 9210674
[TBL] [Abstract][Full Text] [Related]
11. Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae.
Pfaller MA; Messer S; Jones RN
Antimicrob Agents Chemother; 1997 Feb; 41(2):233-5. PubMed ID: 9021172
[TBL] [Abstract][Full Text] [Related]
12. The Orotomide Olorofim Is Efficacious in an Experimental Model of Central Nervous System Coccidioidomycosis.
Wiederhold NP; Najvar LK; Jaramillo R; Olivo M; Birch M; Law D; Rex JH; Catano G; Patterson TF
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941638
[TBL] [Abstract][Full Text] [Related]
13. [A case of coccidioidomycosis in Turkey imported from the United States of America].
Başaran S; Karabıçak N; Şimşek Yavuz S; Wiederhold NP; Şafak S; Sarıbuğa A; Sutton DA; Bingöl Z; Çağatay A; Özsüt H; Kılıçaslan Z; Eraksoy H
Mikrobiyol Bul; 2017 Apr; 51(2):183-190. PubMed ID: 28566083
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp.
Oakley KL; Moore CB; Denning DW
Antimicrob Agents Chemother; 1997 May; 41(5):1124-6. PubMed ID: 9145880
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
[TBL] [Abstract][Full Text] [Related]
16. Utility of the triazole D0870 in the treatment of experimental systemic coccidioidomycosis.
Clemons KV; Stevens DA
J Med Vet Mycol; 1994; 32(4):323-6. PubMed ID: 7983578
[TBL] [Abstract][Full Text] [Related]
17. In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii.
Cordeiro Rde A; Brilhante RS; Rocha MF; Medrano DJ; Monteiro AJ; Tavares JL; de Lima RA; de Camargo ZP; Sidrim JJ
Int J Antimicrob Agents; 2009 Sep; 34(3):278-80. PubMed ID: 19520551
[TBL] [Abstract][Full Text] [Related]
18. Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.
Connolly P; Wheat J; Schnizlein-Bick C; Durkin M; Kohler S; Smedema M; Goldberg J; Brizendine E; Loebenberg D
Antimicrob Agents Chemother; 1999 Feb; 43(2):322-8. PubMed ID: 9925526
[TBL] [Abstract][Full Text] [Related]
19. Efficacies of sordarin derivatives GM193663, GM211676, and GM237354 in a murine model of systemic coccidioidomycosis. p6.
Clemons KV; Stevens DA
Antimicrob Agents Chemother; 2000 Jul; 44(7):1874-7. PubMed ID: 10858347
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of a new triazole antifungal agent, Sch 56592, against clinical isolates of filamentous fungi.
Marco F; Pfaller MA; Messer SA; Jones RN
Mycopathologia; 1998; 141(2):73-7. PubMed ID: 9750338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
